» Articles » PMID: 37818129

Agrin is a Novel Oncogenic Protein in Thyroid Cancer

Overview
Journal Oncol Lett
Specialty Oncology
Date 2023 Oct 11
PMID 37818129
Authors
Affiliations
Soon will be listed here.
Abstract

Agrin (AGRN) is a matricellular glycoprotein involved in extracellular signal transduction. AGRN is involved in tumorigenesis and cancer progression; however, the role of AGRN in thyroid cancer (TC) remains unclear. In the present study, using cell lines derived from various subtypes of TC including CGTH, FTC-133 and BcPAP and transcriptomic data from patients with TC, the role of AGRN in TC was analyzed by migration, invasion, viability and proliferation assays as well as Western blot with EMT markers. AGRN expression was significantly increased in thyroid tumors and cell lines derived from various TC subtypes. The highest AGRN expression was found in follicular and papillary thyroid carcinoma subtypes. Immunocytochemistry revealed nuclear AGRN localization in normal (NTHY) and TC cells. Silencing of AGRN decreased viability, proliferation, migration and invasion of TC cell lines by upregulating vimentin and downregulating N-cadherin and E-cadherin. Furthermore, the expression of AGRN was associated with neutrophil infiltration in thyroid tumors. In conclusion, the present results indicated that increased AGRN expression promoted tumorigenic phenotypes of TC cells, while AGRN expression was associated with immune infiltration in thyroid tumors. AGRN may represent a target for future cancer therapy and requires further evaluation.

Citing Articles

Role of Agrin in tissue repair and regeneration: From mechanisms to therapeutic opportunities (Review).

Li X, Xu Y, Si J, Gu F, Ma Y Int J Mol Med. 2024; 54(5).

PMID: 39301653 PMC: 11410309. DOI: 10.3892/ijmm.2024.5422.


Proteoglycans of basement membranes: Crucial controllers of angiogenesis, neurogenesis, and autophagy.

Mongiat M, Pascal G, Poletto E, Williams D, Iozzo R Proteoglycan Res. 2024; 2(3).

PMID: 39184370 PMC: 11340296. DOI: 10.1002/pgr2.22.


Identification and validation of basement membrane-associated gene AGRN as prognostic and immune-associated biomarkers in colorectal cancer patients.

Li J, You D, Hu L, Yang Y, Gao S, Bai W J Cell Mol Med. 2024; 28(16):e70010.

PMID: 39183444 PMC: 11345205. DOI: 10.1111/jcmm.70010.


Circulatory Agrin Serves as a Prognostic Indicator for Hepatocellular Carcinoma.

Kapoor A, Bayat Mokhtari R, Sonti S, Patel R, George A, Attwood K Cancers (Basel). 2024; 16(15).

PMID: 39123447 PMC: 11312157. DOI: 10.3390/cancers16152719.

References
1.
Kim S, Cho S, Min H, Kim K, Yeom G, Kim E . The expression of tumor-associated macrophages in papillary thyroid carcinoma. Endocrinol Metab (Seoul). 2014; 28(3):192-8. PMC: 3811699. DOI: 10.3803/EnM.2013.28.3.192. View

2.
Wang Z, Sun X, Wang Y, Miao Y . Agrin promotes the proliferation, invasion and migration of rectal cancer cells via the WNT signaling pathway to contribute to rectal cancer progression. J Recept Signal Transduct Res. 2020; 41(4):363-370. DOI: 10.1080/10799893.2020.1811325. View

3.
Scapini P, Cassatella M . Social networking of human neutrophils within the immune system. Blood. 2014; 124(5):710-9. DOI: 10.1182/blood-2014-03-453217. View

4.
Chandrashekar D, Bashel B, Balasubramanya S, Creighton C, Ponce-Rodriguez I, Chakravarthi B . UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia. 2017; 19(8):649-658. PMC: 5516091. DOI: 10.1016/j.neo.2017.05.002. View

5.
Cantwell-Dorris E, OLeary J, Sheils O . BRAFV600E: implications for carcinogenesis and molecular therapy. Mol Cancer Ther. 2011; 10(3):385-94. DOI: 10.1158/1535-7163.MCT-10-0799. View